James M. Anderson - 06 Jan 2023 Form 4 Insider Report for MERIDIAN BIOSCIENCE INC

Role: Director
Signature: /s/ F. Mark Reuter as Attorney-in-Fact for James M. Anderson
Issuer symbol: N/A
Transactions as of: 06 Jan 2023
Net transactions value: +$173,230
Form type: 4
Filing time: 09 Jan 2023, 09:48:54 UTC
Previous filing: 28 Jan 2022
Next filing: 31 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIVO	Common Stock	Options Exercise	$173,230	+8,500	+43%	$20.38	28,224	06 Jan 2023	Direct
holding	VIVO	Common Stock						5,000	06 Jan 2023	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIVO	Stock Options (Right to Buy)	Options Exercise	$0	-8,500	-100%	$0.000000^*	0	06 Jan 2023	Common Stock	8,500	$20.38	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These non-qualified options were awarded under the 2012 Stock Incentive Plan and vested 25% every 90 days from the date of grant and were fully vested on January 18, 2014.